tiprankstipranks
Advertisement
Advertisement

AU:OCC Stock Latest News

Orthocell Issues Cautious Q4 FY26 Investor Presentation Disclaimer
Company AnnouncementsOrthocell Issues Cautious Q4 FY26 Investor Presentation Disclaimer
8d ago
OCC
Orthocell hits record revenue as Remplir adoption accelerates and global rollout advances
PremiumCompany Announcements
Orthocell hits record revenue as Remplir adoption accelerates and global rollout advances
9d ago
OCC
Orthocell to Unveil Quarterly Results and Detail U.S. Rollout of Remplir
PremiumCompany Announcements
Orthocell to Unveil Quarterly Results and Detail U.S. Rollout of Remplir
16d ago
OCC
Orthocell Expands Humanitarian Use of Remplir Nerve Repair Device in Ukraine
PremiumCompany Announcements
Orthocell Expands Humanitarian Use of Remplir Nerve Repair Device in Ukraine
22d ago
OCC
Orthocell issues new shares after employee option exercise under equity incentive plan
PremiumCompany Announcements
Orthocell issues new shares after employee option exercise under equity incentive plan
3M ago
OCC
Orthocell Seeks ASX Quotation for 445,696 New Shares
PremiumCompany AnnouncementsOrthocell Seeks ASX Quotation for 445,696 New Shares
3M ago
OCC
Orthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
Premium
Company Announcements
Orthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
3M ago
OCC
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
Premium
Company Announcements
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
3M ago
OCC
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
PremiumCompany Announcements
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
3M ago
OCC
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
PremiumCompany Announcements
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
3M ago
OCC
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
3M ago
OCC
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
PremiumCompany Announcements
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
3M ago
OCC
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
PremiumCompany AnnouncementsOrthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
3M ago
OCC
Orthocell courts investors with biotech presentation as global product rollout advances
Premium
Company Announcements
Orthocell courts investors with biotech presentation as global product rollout advances
4M ago
OCC
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
Premium
Company Announcements
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
4M ago
OCC
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
PremiumCompany Announcements
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
4M ago
OCC
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
4M ago
OCC
Orthocell director Michael McNulty increases on‑market shareholding
PremiumCompany Announcements
Orthocell director Michael McNulty increases on‑market shareholding
5M ago
OCC
Orthocell Director Increases Shareholding Through On-Market Purchase
PremiumCompany Announcements
Orthocell Director Increases Shareholding Through On-Market Purchase
5M ago
OCC
Orthocell posts record half-year revenue as global expansion gains pace
PremiumCompany AnnouncementsOrthocell posts record half-year revenue as global expansion gains pace
5M ago
OCC
Orthocell Issues Confidential US Market Update with Standard Legal Disclaimers
Premium
Company Announcements
Orthocell Issues Confidential US Market Update with Standard Legal Disclaimers
6M ago
OCC
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
Premium
Company Announcements
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
6M ago
OCC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >